Cryo Cell International (CCEL) Cash from Operations (2010 - 2026)

Cryo Cell International has disclosed Cash from Operations across 17 years of filings, most recently posting 651827.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 31.68% year-over-year to 651827.0; the TTM figure through Feb 2026 stood at 5176370.0 (down 29.3% YoY), while the FY2025 annual figure was 5478606.0, down 8.86% from the prior year.
• Cash from Operations fell to 651827.0 in Q1 2026, from 1280813.0 in the prior quarter.
• Over the last five years, Cash from Operations for CCEL reached as high as 3344314.0 in Q4 2023 and fell as low as 356865.0 in Q1 2024.
• The 5-year median for Cash from Operations is 1942414.0 (2023), against an average of 1743161.41.
• Annual changes were most pronounced in 2024 — Cash from Operations sank 121.71% — and 2025, when it surged 367.35%.
• A 5-year view of Cash from Operations shows it stood at 2429736.0 in 2022, then jumped by 37.64% to 3344314.0 in 2023, then slumped by 35.5% to 2156993.0 in 2024, then plunged by 40.62% to 1280813.0 in 2025, then plunged by 49.11% to 651827.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 651827.0, 1280813.0, and 2536716.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.